Chester County News and Community Website
DEVON, PA — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) announced the acceptance and presentation details of a poster at SLEEP 2021, the 35th Annual Meeting of the Associated Professional Sleep Societies, LLC, …
Read More
WASHINGTON, D.C. — The Federal Trade Commission this week announced its latest law enforcement action to halt deceptive health and efficacy claims in the growing market for cannabidiol (CBD) products. …
Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has issued warning letters to two companies for selling products labeled as containing cannabidiol (CBD) in ways that violate the Federal …
Read More WASHINGTON, D.C. — The U.S. Food and Drug Administration has issued five warning letters to companies for selling products containing cannabidiol (CBD) in ways that violate the Federal Food, Drug, …
Read More DEVON, PA — Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) announced that the U.S. Food and Drug Administration has granted orphan drug designation for cannabidiol (CBD) for use in treating 22q11.2 deletion …
Read More DEVON, PA — Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, provided an update on its Fragile X syndrome …
Read More
The U.S. Food and Drug Administration approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with tuberous sclerosis complex (TSC) in patients one year of age and …
Read More